- Helps in controlling blood sugar levels in adults with type 2 diabetes.
- Reduces the risk of diabetes-related complications such as neuropathy and retinopathy.
- Improves insulin sensitivity and promotes better glycemic control.
- Can be used as an adjunct to diet and exercise for optimal diabetes management.
- May help in weight management as it is associated with a lower risk of weight gain compared to some other diabetes medications.
- Offers a dual mechanism of action, enhancing efficacy in blood sugar regulation.
- Convenient once or twice daily dosing improves adherence to treatment.
Jalra DP 50/5 mg Tablet - Strip of 10
Compositions : Dapagliflozin 5mg + Vildagliptin 50mg
MRP :
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: USV Private Limited
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Jalra DP 50/5 mg Tablet is a pharmaceutical product that combines two active ingredients: Metformin and Sitagliptin. Metformin is an oral antihyperglycemic agent that belongs to the biguanide class, primarily used for managing type 2 diabetes mellitus. Sitagliptin, on the other hand, is a DPP-4 inhibitor that enhances the body's own ability to lower blood sugar levels. The combination of these two medications in Jalra DP 50/5 mg Tablet works synergistically to improve glycemic control in adults with type 2 diabetes. This formulation is particularly beneficial for patients who may not achieve adequate control with Metformin alone. By utilizing both mechanisms of action, Jalra DP 50/5 mg Tablet helps to regulate blood glucose levels effectively, thereby reducing the risk of diabetes-related complications. The product is available in tablet form, making it convenient for daily administration. It is essential for patients to understand the importance of adhering to prescribed dosages and maintaining a healthy lifestyle while using Jalra DP 50/5 mg Tablet to achieve optimal results in managing their diabetes. The therapeutic purpose of Jalra DP 50/5 mg Tablet extends beyond just lowering blood sugar; it also plays a role in improving overall metabolic health, which is crucial for individuals living with diabetes. Regular monitoring of blood glucose levels and consultations with healthcare providers are recommended to ensure the effectiveness of the treatment regimen involving Jalra DP 50/5 mg Tablet.
Product Details
- Metformin decreases hepatic glucose production and increases insulin sensitivity.
- Sitagliptin inhibits the DPP-4 enzyme, leading to increased levels of incretin hormones.
- Increased incretin levels enhance insulin secretion in response to meals.
- Reduces glucagon secretion, which lowers blood glucose levels.
- Improves postprandial (after meal) blood sugar control.
- Take Jalra DP 50/5 mg Tablet orally with or without food as directed by your healthcare provider.
- The usual starting dose is one tablet taken once or twice daily.
- Dosage may be adjusted based on individual blood glucose levels and tolerance.
- Swallow the tablet whole with a glass of water; do not crush or chew.
- Maintain a consistent schedule for taking the medication to optimize its effectiveness.
- Regularly monitor your blood sugar levels as advised by your doctor.
- Do not exceed the prescribed dosage without consulting your healthcare provider.
- Adopt a balanced diet rich in whole grains, fruits, vegetables, and lean proteins to support diabetes management.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise each week.
- Monitor your weight regularly and aim for a healthy body mass index (BMI).
- Avoid excessive consumption of sugary foods and beverages that can spike blood sugar levels.
- Stay hydrated by drinking plenty of water throughout the day.
- Establish a routine for taking your medication to enhance adherence and effectiveness.
Safety Advice
Side Effects
- Common side effects may include nausea, vomiting, diarrhea, abdominal pain, and loss of appetite.
- Some patients may experience headaches or dizziness.
- Serious side effects can include lactic acidosis, which is a rare but severe condition requiring immediate medical attention.
- If you experience symptoms such as unusual tiredness, muscle pain, or difficulty breathing, seek medical help promptly.
- Allergic reactions may occur; watch for signs like rash, itching, or swelling of the face/tongue/throat.
Precautions and Warnings
- Avoid using Jalra DP 50/5 mg Tablet if you have severe kidney impairment or are on dialysis.
- Consult your doctor if you have a history of pancreatitis before starting this medication.
- Use caution if you have liver disease; dosage adjustments may be necessary.
- Avoid alcohol consumption as it can increase the risk of lactic acidosis.
- Pregnant or breastfeeding women should discuss potential risks with their healthcare provider before use.
- Monitor blood sugar levels regularly and report any significant changes to your doctor.
FAQs
If you miss a dose, take it as soon as you remember. If it's almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double up on doses.
2. Can I take Jalra DP 50/5 mg Tablet if I am pregnant?
Consult your healthcare provider before taking Jalra DP 50/5 mg Tablet during pregnancy, as it may not be recommended.
3. Are there any food interactions with Jalra DP 50/5 mg Tablet?
There are no specific food interactions; however, maintaining a balanced diet is crucial while taking this medication.
4. How should I store Jalra DP 50/5 mg Tablet?
Store Jalra DP 50/5 mg Tablet at room temperature away from moisture and heat, and keep it out of reach of children.
5. What are the common side effects of Jalra DP 50/5 mg Tablet?
Common side effects may include gastrointestinal issues such as nausea, diarrhea, or abdominal discomfort.
6. Can I drink alcohol while taking Jalra DP 50/5 mg Tablet?
It is advisable to limit alcohol consumption while taking Jalra DP 50/5 mg Tablet, as it can affect blood sugar levels.
7. Who should avoid using Jalra DP 50/5 mg Tablet?
Individuals with a history of hypersensitivity to Metformin or Sitagliptin should avoid this medication.
Instructions
Directions for Use
Storage and Disposal
More Information
| SKU | 915034 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | USV Private Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Jalra DP 50/5 mg Tablet is a pharmaceutical product that combines two active ingredients: Metformin and Sitagliptin. Metformin is an oral antihyperglycemic agent that belongs to the biguanide class, primarily used for managing type 2 diabetes mellitus. Sitagliptin, on the other hand, is a DPP-4 inhibitor that enhances the body's own ability to lower blood sugar levels. The combination of these two medications in Jalra DP 50/5 mg Tablet works synergistically to improve glycemic control in adults with type 2 diabetes. This formulation is particularly beneficial for patients who may not achieve adequate control with Metformin alone. By utilizing both mechanisms of action, Jalra DP 50/5 mg Tablet helps to regulate blood glucose levels effectively, thereby reducing the risk of diabetes-related complications. The product is available in tablet form, making it convenient for daily administration. It is essential for patients to understand the importance of adhering to prescribed dosages and maintaining a healthy lifestyle while using Jalra DP 50/5 mg Tablet to achieve optimal results in managing their diabetes. The therapeutic purpose of Jalra DP 50/5 mg Tablet extends beyond just lowering blood sugar; it also plays a role in improving overall metabolic health, which is crucial for individuals living with diabetes. Regular monitoring of blood glucose levels and consultations with healthcare providers are recommended to ensure the effectiveness of the treatment regimen involving Jalra DP 50/5 mg Tablet.
- Helps in controlling blood sugar levels in adults with type 2 diabetes.
- Reduces the risk of diabetes-related complications such as neuropathy and retinopathy.
- Improves insulin sensitivity and promotes better glycemic control.
- Can be used as an adjunct to diet and exercise for optimal diabetes management.
- May help in weight management as it is associated with a lower risk of weight gain compared to some other diabetes medications.
- Offers a dual mechanism of action, enhancing efficacy in blood sugar regulation.
- Convenient once or twice daily dosing improves adherence to treatment.
- Metformin decreases hepatic glucose production and increases insulin sensitivity.
- Sitagliptin inhibits the DPP-4 enzyme, leading to increased levels of incretin hormones.
- Increased incretin levels enhance insulin secretion in response to meals.
- Reduces glucagon secretion, which lowers blood glucose levels.
- Improves postprandial (after meal) blood sugar control.
- Take Jalra DP 50/5 mg Tablet orally with or without food as directed by your healthcare provider.
- The usual starting dose is one tablet taken once or twice daily.
- Dosage may be adjusted based on individual blood glucose levels and tolerance.
- Swallow the tablet whole with a glass of water; do not crush or chew.
- Maintain a consistent schedule for taking the medication to optimize its effectiveness.
- Regularly monitor your blood sugar levels as advised by your doctor.
- Do not exceed the prescribed dosage without consulting your healthcare provider.
- Adopt a balanced diet rich in whole grains, fruits, vegetables, and lean proteins to support diabetes management.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise each week.
- Monitor your weight regularly and aim for a healthy body mass index (BMI).
- Avoid excessive consumption of sugary foods and beverages that can spike blood sugar levels.
- Stay hydrated by drinking plenty of water throughout the day.
- Establish a routine for taking your medication to enhance adherence and effectiveness.
Side Effects
- Common side effects may include nausea, vomiting, diarrhea, abdominal pain, and loss of appetite.
- Some patients may experience headaches or dizziness.
- Serious side effects can include lactic acidosis, which is a rare but severe condition requiring immediate medical attention.
- If you experience symptoms such as unusual tiredness, muscle pain, or difficulty breathing, seek medical help promptly.
- Allergic reactions may occur; watch for signs like rash, itching, or swelling of the face/tongue/throat.
Precautions and Warnings
- Avoid using Jalra DP 50/5 mg Tablet if you have severe kidney impairment or are on dialysis.
- Consult your doctor if you have a history of pancreatitis before starting this medication.
- Use caution if you have liver disease; dosage adjustments may be necessary.
- Avoid alcohol consumption as it can increase the risk of lactic acidosis.
- Pregnant or breastfeeding women should discuss potential risks with their healthcare provider before use.
- Monitor blood sugar levels regularly and report any significant changes to your doctor.
If you miss a dose, take it as soon as you remember. If it's almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double up on doses.
2. Can I take Jalra DP 50/5 mg Tablet if I am pregnant?
Consult your healthcare provider before taking Jalra DP 50/5 mg Tablet during pregnancy, as it may not be recommended.
3. Are there any food interactions with Jalra DP 50/5 mg Tablet?
There are no specific food interactions; however, maintaining a balanced diet is crucial while taking this medication.
4. How should I store Jalra DP 50/5 mg Tablet?
Store Jalra DP 50/5 mg Tablet at room temperature away from moisture and heat, and keep it out of reach of children.
5. What are the common side effects of Jalra DP 50/5 mg Tablet?
Common side effects may include gastrointestinal issues such as nausea, diarrhea, or abdominal discomfort.
6. Can I drink alcohol while taking Jalra DP 50/5 mg Tablet?
It is advisable to limit alcohol consumption while taking Jalra DP 50/5 mg Tablet, as it can affect blood sugar levels.
7. Who should avoid using Jalra DP 50/5 mg Tablet?
Individuals with a history of hypersensitivity to Metformin or Sitagliptin should avoid this medication.
Directions for Use
Storage and Disposal
| SKU | 915034 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | USV Private Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account